A Study of HTD1801 in Healthy Subjects

NCT03099603 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Sclerosing Cholangitis

Interventions

DRUG: HTD1801

Sponsor

HighTide Biopharma Pty Ltd